Pediatrix Medical Group, Inc. (NYSE:MD) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lessened its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 15.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,158,240 shares of the company's stock after selling 209,105 shares during the period. Charles Schwab Investment Management Inc. owned 1.35% of Pediatrix Medical Group worth $15,196,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of MD. Rubric Capital Management LP boosted its position in Pediatrix Medical Group by 1.5% during the third quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company's stock worth $95,907,000 after acquiring an additional 125,000 shares during the last quarter. State Street Corp grew its position in shares of Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company's stock valued at $41,038,000 after purchasing an additional 50,597 shares in the last quarter. Pacer Advisors Inc. purchased a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at approximately $35,492,000. Geode Capital Management LLC increased its holdings in shares of Pediatrix Medical Group by 2.4% in the third quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company's stock valued at $22,452,000 after purchasing an additional 45,155 shares during the last quarter. Finally, Weiss Asset Management LP lifted its position in Pediatrix Medical Group by 50.5% during the third quarter. Weiss Asset Management LP now owns 912,818 shares of the company's stock worth $10,580,000 after buying an additional 306,143 shares in the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on MD shares. Macquarie began coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an "outperform" rating and a $18.00 price objective on the stock. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. UBS Group boosted their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. Finally, Truist Financial raised their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research report on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Pediatrix Medical Group presently has a consensus rating of "Hold" and an average price target of $17.08.

Pediatrix Medical Group Stock Up 2.1 %

Shares of NYSE MD traded up $0.30 during mid-day trading on Monday, hitting $14.51. The company had a trading volume of 593,809 shares, compared to its average volume of 811,255. The company has a market capitalization of $1.25 billion, a PE ratio of -12.09, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. The business's 50-day simple moving average is $14.31 and its 200 day simple moving average is $13.55. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. On average, analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.